Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial

Arthritis and Rheumatology - United Kingdom
doi 10.1002/art.40358

Related search